Literature DB >> 8401356

Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study.

P Saugier-Veber1, A Devergie, A Sulahian, P Ribaud, F Traore, H Bourdeau-Esperou, E Gluckman, F Derouin.   

Abstract

Of 322 patients undergoing allogeneic BMT, 18 developed invasive pulmonary aspergillosis at a mean of 115 days post-transplant, with a mortality rate of 82%. Pulmonary localization was common but cerebral involvement was seen in 10 of 18 patients. The diagnosis was made ante mortem in 11 patients by direct examination of pathological samples or culture and A. fumigatus was the only species isolated. Specific antibodies were not demonstrated before or at the time of clinical symptoms and Aspergillus antigen was only seen in one patient a few days before death.

Entities:  

Mesh:

Year:  1993        PMID: 8401356

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  18 in total

1.  Disseminated invasive aspergillosis.

Authors:  A Aleksenko; Rk Gyasi
Journal:  Ghana Med J       Date:  2006-06

Review 2.  Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature.

Authors:  Joel W Alderson; Thomas G Van Dinter; Michael J Opatowsky; Elizabeth C Burton
Journal:  MedGenMed       Date:  2005-09-21

3.  Fungicidal activity of cecropin A.

Authors:  A J DeLucca; J M Bland; T J Jacks; C Grimm; T E Cleveland; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

Review 4.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Panfungal PCR assay for detection of fungal infection in human blood specimens.

Authors:  J A Van Burik; D Myerson; R W Schreckhise; R A Bowden
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 6.  Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients.

Authors:  J Beyer; S Schwartz; V Heinemann; W Siegert
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

Review 7.  Granulocyte transfusion in the G-CSF era.

Authors:  Thomas H Price
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 8.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

9.  Comparison of commercial latex agglutination and sandwich enzyme immunoassays with a competitive binding inhibition enzyme immunoassay for detection of antigenemia and antigenuria in a rabbit model of invasive aspergillosis.

Authors:  S F Hurst; G H Reyes; D W McLaughlin; E Reiss; C J Morrison
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

10.  Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Dieter Buchheidt; Corinna Baust; Heyko Skladny; Wolfgang Seifarth; Udo Zeilfelder; Christine Leib-Mösch; Handan Mörz; Rüdiger Hehlmann
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.